HER2/neu-Based Peptide Vaccination-Pulsed with B-Cell Epitope Induced Efficient Prophylactic and Therapeutic Antitumor Activities in TUBO Breast Cancer Mice Model

SIMPLE SUMMARY: Recently, the role of vaccination has been expanded in the management of HER2/neu-positive breast cancer. Data from various clinical trials indicated that an effective breast cancer vaccine must be able to induce both humoral and cellular immune responses. One approach is the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordin, Muhammad Luqman, Mohamad Norpi, Abdin Shakirin, Ng, Pei Yuen, Yusoff, Khatijah, Abu, Nadiah, Lim, Kue Peng, Azmi, Fazren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507975/
https://www.ncbi.nlm.nih.gov/pubmed/34638441
http://dx.doi.org/10.3390/cancers13194958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507975/
https://www.ncbi.nlm.nih.gov/pubmed/34638441
http://dx.doi.org/10.3390/cancers13194958

Ejemplares similares